Abstract:Although myocyte cell transplantation studies have suggested a promising therapeutic potential for myocardial infarction, a major obstacle to the development of clinical therapies for myocardial repair is the difficulties associated with obtaining relatively homogeneous ventricular myocytes for transplantation. Human embryonic stem cells (hESCs) are a promising source of cardiomyocytes. Here we report that retinoid signaling regulates the fate specification of atrial versus ventricular myocytes during cardiac differentiation of hESCs. We found that both Noggin and the pan-retinoic acid receptor antagonist BMS-189453 (RAi) significantly increased the cardiac differentiation efficiency of hESCs. To investigate retinoid functions, we compared Noggin+RAi-treated cultures with Noggin+RA-treated cultures. Our results showed that the expression levels of the ventricular-specific gene IRX-4 were radically elevated in Noggin+RAi-treated cultures. MLC-2V, another ventricular-specific marker, was expressed in the majority of the cardiomyocytes in Noggin+RAi-treated cultures, but not in the cardiomyocytes of Noggin+RA-treated cultures. Flow cytometry analysis and electrophysiological studies indicated that with 64.7 ± 0.88% (mean ±s.e.m) cardiac differentiation efficiency, 83% of the cardiomyocytes in Noggin+RAi-treated cultures had embryonic ventricular-like action potentials (APs). With 50.7 ± 1.76% cardiac differentiation efficiency, 94% of the cardiomyocytes in Noggin+RA-treated cultures had embryonic atrial-like APs. These results were further confirmed by imaging studies that assessed the patterns and properties of the Ca(2+) sparks of the cardiomyocytes from the two cultures. These findings demonstrate that retinoid signaling specifies the atrial versus ventricular differentiation of hESCs. This study also shows that relatively homogeneous embryonic atrial- and ventricular-like myocyte populations can be efficiently derived from hESCs by specifically regulating Noggin and retinoid signals.

Directed Mouse Embryonic Stem Cells into Leydig-Like Cells Rescue Testosterone-Deficient Male Rats in Vivo.

Differentiation of Adult Stem Cells Derived from Bone Marrow Stroma into Leydig or Adrenocortical Cells.

Differentiation of human induced pluripotent stem cells into Leydig-like cells with molecular compounds

Stem Leydig Cells in the Adult Testis: Characterization, Regulation and Potential Applications

Construction of directional differentiation model from mouse embryonic stem cells to Leydig-like cells in vitro]

Leydig-like Cells Derived from Reprogrammed Human Foreskin Fibroblasts by CRISPR/dCas9 Increase the Level of Serum Testosterone in Castrated Male Rats

Differentiation of bone marrow mesenchymal stem cells into Leydig-like cells with testicular extract liquid in vitro

Proliferated Leydig cells for engineered testis-like tissue regeneration with testosterone-secreting ability

Leydig cell transplantation restores androgen production in surgically castrated prepubertal rats.

Transplanted Human P75-Positive Stem Leydig Cells Replace Disrupted Leydig Cells for Testosterone Production

Direct Differentiation of Atrial and Ventricular Myocytes from Human Embryonic Stem Cells by Alternating Retinoid Signals

[Progress on the Research of Stem Leydig Cell Line in the Testis of Rodents].

Transplantation of CD51+ Stem Leydig Cells: A New Strategy for the Treatment of Testosterone Deficiency

Androgen-Forming Stem Leydig Cells: Identification, Function and Therapeutic Potential

CRISPR/dCas9-mediated Activation of Multiple Endogenous Target Genes Directly Reprograms Human Foreskin Fibroblasts into Leydig-like Cells

Directing differentiation of human induced pluripotent stem cells toward androgen-producing Leydig cells rather than adrenal cells

Gonadotropins Facilitate Potential Differentiation of Human Bone Marrow Mesenchymal Stem Cells into Leydig Cells in Vitro.

Transplantation of encapsulated human Leydig-like cells: A novel option for the treatment of testosterone deficiency

Efficient Generation of Male Germ-Like Cells Derived During Co-Culturing of Adipose-Derived Mesenchymal Stem Cells with Sertoli Cells under Retinoic Acid and Testosterone Induction

Characterization of Nestin-positive stem Leydig cells as a potential source for the treatment of testicular Leydig cell dysfunction

Reconstructing the Stem Leydig Cell Niche via the Testicular Extracellular Matrix for the Treatment of Testicular Leydig Cell Dysfunction